Peer-to-peer Roundtable with Quang Pham

PS27 Founders shared their stories and questions with Quang Pham who is the Founder, Chairman & CEO of Espero BioPharma.

In 2015, Mr. Pham founded Espero, a biopharmaceutical company focusing on the late-stage development and commercialization of medicines to treat cardiovascular diseases, the leading cause of death worldwide. Espero has three FDA-approved drugs and a robust clinical pipeline.

He also founded Lathian Systems, an innovative company that provided online data and marketing services to pharmaceutical and biotech companies. As Chairman and CEO, he raised $14 million in venture capital and corporate funding for Lathian, grew the business, and led its eventual sale to D&R Communications, a direct marketing company.

Following service as a U.S. Marine Corps aviator, Mr. Pham began his business career in sales roles with Merck and Genentech. He is a published author and holds a B.A. in Economics from UCLA. He has also received the BioFlorida’s Entrepreneur of the Year Award, named a Veteran of Influence by the Jacksonville Business Journal (JBJ) and recognized as a finalist for the Ernst & Young Entrepreneur Of The Year® 2017 Award. In July, the JBJ recognized Espero as the fastest growing private company in Northeast Florida.

He currently serves on the Board of BioFlorida and is a past director of InHouseUSA, Inc., the Marine Corps Scholarship Foundation and the Chapman University Argyros School Board of Advisors.